GENSCRIPT BIO (01548) Schedules Board Meeting for 15 March 2026

Bulletin Express03-04

GENSCRIPT BIO (01548) has announced that a Board meeting will be held on 15 March 2026. The main objectives include reviewing and approving annual results for the year ended 31 December 2025, releasing these results, and considering the payment of an annual dividend, if any. The announcement is dated 4 March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment